Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Neil McIsaac & Son, Inc.
WARNING LETTER
•Neil McIsaac & Son, Inc.•July 19, 2010

FDA WARNING_LETTER - Neil McIsaac & Son, Inc. - July 19, 2010

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On July 7 and 19, 2010, the FDA investigated Neil McIsaac & Son, Inc.'s dairy operation in Petaluma, California, identifying multiple violations of the Federal Food, Drug, and Cosmetic Act.

A dairy cow sold for slaughter on April 20, 2010, was found to have penicillin in its kidney at 0.55 ppm, exceeding the 0.05 ppm tolerance (21 C.F.R. 556.510), rendering the food adulterated under section 402(a)(2)(C)(ii) of the Act. The investigation also revealed insanitary conditions, specifically a failure to maintain complete treatment records, leading to the likelihood of medicated animals with harmful drug residues entering the food supply, thus adulterating food under section 402(a)(4).

Furthermore, the company adulterated new animal drugs Penicillin G Procaine and Ceftiofur by using them extralabelly without proper veterinary supervision, violating 21 C.F.R. 530.11(a). Specifically, Penicillin G Procaine was administered to two cows without observing the veterinarian's prescribed withdrawal period, resulting in illegal drug residues (21 C.F.R. 530.11(d)). Ceftiofur was administered to another cow without following the approved labeling's frequency of

Company
Neil McIsaac & Son, Inc.
Inspection Date
July 19, 2010
Product Type
Drugs
Office
Department of Health and Human Services
Person
  • Barbara J. Cassens (Director )
Open in Dashboard

ID · 813c0eae-a38c-40e5-b4c2-23b752a66097

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 556.51021 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 53021 CFR 530.11(a)21 CFR 530.11(d)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.